BEN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Franklin Resources (BEN) is not a strong buy right now for a Beginner long-term investor with $50,000-$100,000 who wants to act now rather than wait. The stock has some improving fundamentals and analysts are becoming more constructive, but the current setup is mixed: price is only slightly above the prior close, momentum is not confirmed, and there is no Intellectia proprietary buy signal today. My direct view is HOLD, not buy, at this moment.
Current price is 31.235 with the market closed and the stock finished slightly above the previous close, but the regular session showed a -1.45% decline, so near-term price action is weak. MACD histogram is -0.214 and negative/expanding, which points to weakening momentum. RSI_6 at 48.94 is neutral, so there is no oversold buy setup. The moving averages are structurally bullish (SMA_5 > SMA_20 > SMA_200), which supports the longer-term trend, but the stock is trading below the pivot of 31.477 and below R1 at 32.205, leaving limited immediate upside unless it reclaims resistance. Overall, trend is mixed: longer-term trend constructive, short-term momentum soft.
Analyst tone has improved meaningfully. Morgan Stanley upgraded BEN to Equal Weight from Underweight and raised its target to $31 from $21, citing early turnaround signs, fading Western outflows, and improving core flows. Goldman Sachs and TD Cowen both maintain Buy ratings with higher targets of $34 and $37, respectively, and both highlighted stronger-than-expected Q2 results, improving private markets fundraising, better flow commentary, expense control, and margin expansion potential. Barclays also upgraded to Equal Weight from Underweight, pointing to improving fundamentals, higher guidance, and solid cost control. The stock also has bullish options positioning and the moving-average structure remains favorable for the longer term.
There was no news in the recent week, so there is no immediate event-driven catalyst. Short-term momentum is weak with a negative MACD histogram and a recent daily decline. Congress trading data is slightly negative overall, with 2 sale transactions versus 1 purchase, suggesting cautious sentiment among lawmakers. Hedge funds and insiders are both neutral, showing no strong conviction buying. The financial snapshot data was unavailable, so the latest-quarter operating confirmation is limited in this dataset.
Latest quarter season information from the analyst notes points to fiscal Q2 strength. Analysts cited stronger-than-expected Q2 results, improving momentum in private markets fundraising, better fee-related earnings, accelerating organic growth, and strong evergreen inflows. They also mentioned disciplined expense management and a faster path toward margin expansion. Since the formal financial snapshot was unavailable, the assessment is based on those reported Q2 commentary trends rather than a full income statement review.
Analyst sentiment has improved recently. Several firms raised price targets on 2026-04-29 and 2026-05-06, including Morgan Stanley's upgrade to Equal Weight and target increase to $31, Barclays' upgrade to Equal Weight and target to $31, TD Cowen's Buy with $37 target, Goldman Sachs' Buy with $34 target, and JPMorgan's Neutral with $31 target. The main positive theme is a growing belief in a turnaround, better flows, and margin improvement. The bear case still exists, with Evercore ISI and BofA remaining Underperform/Underweight-type views and targets mostly clustered around the low-to-mid $20s to low $30s. Wall Street is therefore split, but the latest direction is clearly more constructive than before.
